19 June 2013
Keywords: aclasta, effective, risedronate, study, published, april, issue
Article | 14 April 2009
A study published in the April 14 issue of The Lancet shows that a once-yearly infusion of Novartis' Aclasta (zoledronic acid) 5 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 April 2009
15 April 2009
© 2013 thepharmaletter.com